Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 2
2(66.7%)
N/A
1(33.3%)
3Total
Phase 2(2)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT06697561Not ApplicableActive Not Recruiting

Development and Evaluation of an Evidence-based Education Program for People With Hand Dysfunction in Scleroderma

Role: collaborator

NCT01603667Phase 2Completed

PG2 Injection 500 mg in Acute Stroke Study (Pass)

Role: collaborator

NCT00822328Phase 2Completed

Fermented Milk Drink on Human Intestinal Microflora

Role: lead

All 3 trials loaded